[go: up one dir, main page]

DE60123109D1 - Mit schizophrenie in zusammenhang stehendes gen, das für ein potential-abhängiges ionkanal kodiert - Google Patents

Mit schizophrenie in zusammenhang stehendes gen, das für ein potential-abhängiges ionkanal kodiert

Info

Publication number
DE60123109D1
DE60123109D1 DE60123109T DE60123109T DE60123109D1 DE 60123109 D1 DE60123109 D1 DE 60123109D1 DE 60123109 T DE60123109 T DE 60123109T DE 60123109 T DE60123109 T DE 60123109T DE 60123109 D1 DE60123109 D1 DE 60123109D1
Authority
DE
Germany
Prior art keywords
schizophrenia
ion channel
genus
generating
dependent ion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60123109T
Other languages
English (en)
Other versions
DE60123109T2 (de
Inventor
Daniel Cohen
Ilya Chumakov
Anne-Marie Simon
Hadi Abderrahim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Biodevelopment SAS
Original Assignee
Serono Genetics Institute SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Genetics Institute SA filed Critical Serono Genetics Institute SA
Publication of DE60123109D1 publication Critical patent/DE60123109D1/de
Application granted granted Critical
Publication of DE60123109T2 publication Critical patent/DE60123109T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychiatry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Plant Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60123109T 2000-12-05 2001-12-04 Mit schizophrenie in zusammenhang stehendes gen, das für ein potential-abhängiges ionkanal kodiert Expired - Fee Related DE60123109T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25131700P 2000-12-05 2000-12-05
US251317P 2000-12-05
PCT/IB2001/002798 WO2002046404A2 (en) 2000-12-05 2001-12-04 Schizophrenia-related voltage-gated ion channel gene and protein

Publications (2)

Publication Number Publication Date
DE60123109D1 true DE60123109D1 (de) 2006-10-26
DE60123109T2 DE60123109T2 (de) 2007-05-16

Family

ID=22951418

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60123109T Expired - Fee Related DE60123109T2 (de) 2000-12-05 2001-12-04 Mit schizophrenie in zusammenhang stehendes gen, das für ein potential-abhängiges ionkanal kodiert

Country Status (16)

Country Link
US (2) US20040091497A1 (de)
EP (1) EP1339840B1 (de)
JP (1) JP2004525614A (de)
KR (1) KR20030074643A (de)
CN (1) CN1777676A (de)
AT (1) ATE339500T1 (de)
AU (2) AU3357302A (de)
BR (1) BR0115937A (de)
CA (1) CA2430712A1 (de)
DE (1) DE60123109T2 (de)
EA (2) EA008252B1 (de)
ES (1) ES2271092T3 (de)
IL (1) IL156073A0 (de)
MX (1) MXPA03005069A (de)
UA (1) UA79927C2 (de)
WO (1) WO2002046404A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020042100A1 (en) * 2000-07-03 2002-04-11 Chunhua Yan Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
JPWO2002101035A1 (ja) * 2001-05-10 2004-09-24 持田製薬株式会社 新規な電位依存性カチオンチャネル蛋白質
US7634363B2 (en) 2005-12-07 2009-12-15 Affymetrix, Inc. Methods for high throughput genotyping
GB2449819A (en) * 2006-02-28 2008-12-03 Univ California Genes differentially expressed in bipolar disorder and/or schizophrenia
FR2906532B1 (fr) * 2006-09-28 2008-12-12 Biomerieux Sa Nouvel oligonucleotide marque
EP3207051A4 (de) * 2014-10-13 2018-02-28 Dow AgroSciences LLC Nukleinsäuremoleküle aus einer copi-coatomer-alpha-subeinheit zur verleihung von resistenz gegen coleoptera- und hemiptera-schädlingen
KR102807004B1 (ko) * 2020-01-03 2025-05-14 삼성전자주식회사 기판 적층 구조를 포함하는 전자 장치
CN114982679B (zh) * 2022-07-22 2023-08-01 中国水产科学研究院长江水产研究所 一种黄鳝家系建立及优良家系选育方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008001A (en) * 1993-11-05 1999-12-28 Yeda Research And Development Co. Ltd. Diagnosis of the susceptibility of contracting schizophrenia
AU8580598A (en) * 1997-07-22 1999-02-16 Millennium Pharmaceuticals, Inc. Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
DE69836229T2 (de) * 1997-12-03 2007-08-23 Merck & Co., Inc. Zusammensetzungen von durch niedervolt aktivierten kalziumkanälen und verfahren
AU3530299A (en) * 1998-04-30 1999-11-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) A highly conserved polynucleotide sequence linked to a genetic predisposition toschizophrenia, a method of diagnosis, and applications thereof
AU4682999A (en) * 1998-06-16 2000-01-05 Human Genome Sciences, Inc. 94 human secreted proteins
WO2000022122A2 (en) * 1998-10-13 2000-04-20 Genset Genes, proteins and biallelic markers related to central nervous system disease
WO2000058510A2 (en) * 1999-03-30 2000-10-05 Genset Schizophrenia associated genes, proteins and biallelic markers
WO2001083752A2 (en) * 2000-04-29 2001-11-08 Millennium Pharmaceuticals, Inc. 23949 and 32391, human ion channels and uses thereof
CA2415808A1 (en) * 2000-07-07 2002-01-17 Incyte Genomics, Inc. Transporters and ion channels

Also Published As

Publication number Publication date
EA200500974A1 (ru) 2006-02-24
EA008252B1 (ru) 2007-04-27
DE60123109T2 (de) 2007-05-16
EA200300642A1 (ru) 2003-12-25
US20080184381A1 (en) 2008-07-31
ATE339500T1 (de) 2006-10-15
WO2002046404A3 (en) 2002-12-12
ES2271092T3 (es) 2007-04-16
CA2430712A1 (en) 2002-06-13
UA79927C2 (en) 2007-08-10
EP1339840B1 (de) 2006-09-13
KR20030074643A (ko) 2003-09-19
WO2002046404A9 (en) 2002-08-15
US20040091497A1 (en) 2004-05-13
CN1777676A (zh) 2006-05-24
AU2002233573B2 (en) 2007-03-01
WO2002046404A2 (en) 2002-06-13
IL156073A0 (en) 2003-12-23
EA006367B1 (ru) 2005-12-29
BR0115937A (pt) 2003-09-30
EP1339840A2 (de) 2003-09-03
AU3357302A (en) 2002-06-18
MXPA03005069A (es) 2003-09-05
JP2004525614A (ja) 2004-08-26

Similar Documents

Publication Publication Date Title
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
WO2001070174A3 (en) Vegf-modulated genes and methods employing them
DK1000146T3 (da) 5' EST'er for non-vævsspecifikke secernerede proteiner
ATE517915T1 (de) Methode zur identifikation gen-regulierender peptide
DK1378571T3 (da) 5' ESTs for sekreterede proteiner udtrykt i forskellige væv
WO2002029086A3 (en) Nucleic acid sequences differentially expressed in cancer tissue
NZ531570A (en) DNA sequences for human angiogenesis genes
ATE361933T1 (de) 5' ests für sekretierte proteine aus gehirngeweben
DK0750672T3 (da) DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse
NZ592911A (en) Leukolectins and uses thereof
WO2003010336A3 (de) Molekulare marker beim hepatozellulären karzinom
DE60123109D1 (de) Mit schizophrenie in zusammenhang stehendes gen, das für ein potential-abhängiges ionkanal kodiert
DE69834727D1 (de) 5' ests für sekretierte proteine die in verschiedenen geweben expremiert werden
WO2001068854A3 (en) Fibroblast growth factor-like molecules and uses thereof
WO1998006841A3 (en) Two human nsp-like proteins
EP1536006A4 (de) Krebsantigene und deren nutzung
ATE122727T1 (de) Zubereitungen und verfahren für klone, die, mit mehrfacharzneimittelresistenz assoziierte, dna- sequenzen in menschlichen zellen enthalten.
WO1999046374A3 (de) Menschliche nukleinsäuresequenzen aus prostatatumorgewebe
NZ518458A (en) Isolate DNA polymerase lambda and uses thereof
WO2023066873A3 (en) Guide rna and uses thereof
DE60120187D1 (de) Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen
WO2004020582A3 (en) Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr6 genes
WO2001040493A3 (en) Schizophrenia associated gene, proteins and biallelic markers
ATE374260T1 (de) Asthma-assoziiertes gen
WO2003040320A3 (en) Antisense modulation of human collapsin response mediator protein 2 expression

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee